Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
Fenwick, JD; Landau, DB; Baker, AT; Bates, AT; Eswar, C; Garcia-Alonso, A; Harden, SV; Illsley, MC; Laurence, V; Malik, Z; Mayles, WPM; Miles, E; Mohammed, N; Spicer, J; Wells, P; Vivekanandan, S; Mullin, AM; Hughes, L; Farrelly, L; Ngai, Y; Counsell, N
Landau, DB (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020; 106 (4): 733